The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Mauna Kea Technologies is looking to raise up to $67 million through an initial public offering of 3.29 million shares on the NYSE Euronext stock exchange.
The offering will priced between 10.65 euros and 13 euros a share and is expected to close on July 4, according to Reuters news service .
Stem cell therapy company Aldagen is pulling back on its plans for an initial public offering.
The Durham, N.C.-based company revealed in a filing with the Securities & Exchange Commission that it is withdrawing its IPO plans due to market conditions.”
The company in 2009 filed a registration statement seeking to raise more than $80 million to take its compounds into mid-stage clinical trials.
It took a long time to get there, but BG Medicine Inc. (NSDQ:BGMD) ended its first week as a public company in Wall Street’s good graces.
The Waltham, Mass.-based diagnostics company saw share prices jump 5 percent during its first week of public trading, based on the Feb. 17 closing price of $8.39. Shares were up 1.5 percent through mid-day trading today, to $8.58, before retreating slightly.
All in all, it was a big week for the company — CEO Pieter Muntendam even got a chance to ring the NASDAQ exchange’s opening bell Feb. 16.
As Kips Bay Medical awaits an estimated $21.2 million initial public offering, it’s also rolling out its first product in Europe.
The Minneapolis-based company won CE Mark approval to begin selling its eSVS Mesh product in Europe last May. Since then it’s shipped only about 165 units in half a dozen countries, according to the company’s IPO registration filing with the Securities & Exchange Commission.
BG Medicine Inc. (NSDQ:BGMD) entered public trading as the belle of the ball today, after slashing its share price in half earlier in the week.
The Waltham, Mass.-based healthcare diagnostics company’s stock price rose more than 10 percent through late-day trading today, its first, bucking a tepid day for the Dow Jones and NASDAQ exchanges.
BG Medicine Inc. is going ahead with plans for an initial public offering, but halved the amount it hoped to raise.
The Waltham, Mass.-based company is now looking to raise about $33.3 million, less than half the value of the reported $71.2 million IPO the company attempted in December 2010.
NMT Medical Inc. (NSDQ:NMTI) is looking to raise $30 million through a public stock offering to bring its STARFlex cardiac implant through the regulatory process and into the marketplace.
The Boston-based cardiac implant maker said it needs the money because it’s low on cash reserves and heavily leveraged. NMT only has about $9 million in cash reserves and has amassed more than $50 million in debt, according to a prospectus filed with the federal Securities & Exchange Commission.
